← Scroll for more →
LENZ Therapeutics, Inc. (LENZ)
Biological Products, (No Diagnostic Substances)
Latest Price
$3.05
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
6.99
P/B Ratio
0.44
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 4.18M | $23.0M | 13.30% | -- | 2026-06-30 |
| Alpha Wave Global, LP | 3.61M | $20.0M | 11.50% | -- | 2026-06-30 |
| FMR LLC | 3.56M | $20.0M | 11.33% | -38.9K | 2026-06-30 |
| Versant Venture Management, LLC | 2.66M | $15.0M | 8.46% | -- | 2026-06-30 |
| BlackRock, Inc. | 2.29M | $13.0M | 7.30% | +315.3K | 2026-06-30 |
| Squarepoint Ops LLC | 1.75M | $9.0M | 5.56% | +240.6K | 2026-06-30 |
| Aberdeen Group plc | 1.55M | $8.0M | 4.93% | +391.7K | 2026-06-30 |
| Millennium Management LLC | 1.51M | $8.0M | 4.80% | +639.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.10M | $6.0M | 3.49% | +56.6K | 2026-06-30 |
| 72 Investment Holdings, LLC | 1.02M | $5.0M | 3.24% | -- | 2026-06-30 |